Bone Biologics reschedules 2026 shareholder meeting
Bone Biologics Corporation postponed its 2026 annual meeting of stockholders, originally set for August 11, 2026, to September 28, 2026 at 11:30 a.m. Eastern Time at its Burlington, Massachusetts offices.
Rhea-AI Filing Summary
Bone Biologics Corporation postponed its 2026 annual meeting of stockholders, originally set for August 11, 2026, to September 28, 2026 at 11:30 a.m. Eastern Time at its Burlington, Massachusetts offices.
The Board plans to file a Definitive Proxy Statement on Schedule 14A including an additional proposal and concluded more time is needed for stockholders to review materials. The new record date is August 6, 2026, and the deadline for stockholder nominations or other business is July 26, 2026.
Positive
- None.
Negative
- None.
8-K Event Classification
Item 8.01 — Other Events
1 item
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Key Figures
Rescheduled annual meeting date: September 28, 2026
Original annual meeting date: August 11, 2026
Meeting time: 11:30 a.m. Eastern Time
+2 more
5 metrics
Rescheduled annual meeting date
September 28, 2026
Date of Bone Biologics Corporation 2026 annual meeting of stockholders
Original annual meeting date
August 11, 2026
Prior scheduled date for the 2026 annual meeting before postponement
Meeting time
11:30 a.m. Eastern Time
Time of the rescheduled 2026 annual meeting on September 28, 2026
Record date
August 6, 2026
Record date for stockholders entitled to vote at the 2026 annual meeting
Proposal and nomination deadline
July 26, 2026
Deadline for stockholder submissions of director nominees or other business
Key Terms
Definitive Proxy Statement, Schedule 14A, record date, annual meeting of stockholders, +1 more
5 terms
Definitive Proxy Statement regulatory
"The company intends to file a Definitive Proxy Statement on Schedule 14A"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
Schedule 14A regulatory
"Intends to file a Definitive Proxy Statement on Schedule 14A with the SEC"
Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.
record date regulatory
"The new record date for the Annual Meeting will be August 6, 2026"
The record date is the specific day when a company determines which shareholders are eligible to receive a dividend or participate in an upcoming vote. It’s like a cutoff date; if you own the stock on that day, you get the benefits or voting rights. This date matters because it decides who qualifies for certain company benefits.
annual meeting of stockholders regulatory
"Postpone the 2026 annual meeting of stockholders previously scheduled for August 11, 2026"
Board of Directors regulatory
"On July 15, 2026, the Board of Directors of Bone Biologics Corporation"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When will Bone Biologics (BBLG) hold its rescheduled 2026 annual meeting?
Bone Biologics will hold its 2026 annual meeting on September 28, 2026, at 11:30 a.m. Eastern Time. The meeting will take place at the company’s offices, 2 Burlington Woods Drive, Ste. 100, Burlington, MA 01803.
Why did Bone Biologics (BBLG) postpone its 2026 annual meeting?
The Board postponed the meeting to allow time to file a Definitive Proxy Statement on Schedule 14A that includes an additional proposal and to provide stockholders more time to review and consider the proxy materials before voting.
What is the new record date for Bone Biologics (BBLG) 2026 annual meeting?
The new record date for the 2026 annual meeting is August 6, 2026. Stockholders of record as of that date will be entitled to receive notice of and vote at the rescheduled annual meeting on September 28, 2026.
What is the deadline for Bone Biologics (BBLG) stockholder proposals or director nominations?
The deadline for stockholder submissions of director nominees or other business for the 2026 annual meeting is July 26, 2026, which is ten calendar days following the date of the company’s current report about the postponement.
Where will Bone Biologics (BBLG) hold its 2026 annual meeting?
The 2026 annual meeting will be held at Bone Biologics’ offices at 2 Burlington Woods Drive, Ste. 100, Burlington, MA 01803. The meeting is scheduled for 11:30 a.m. Eastern Time on September 28, 2026.
AI-generated analysis. How Rhea-AI works. Not financial advice.
